Showing 1 posts of 1 posts found.
Roche has signed a deal with Evolva Holding to create anti-infectives and cancer treatments using the latter’s genetic chemistry technology. Roche’s …
Weber is new CMO at Sensorion
Charity commits £800,000 to AI research into late breast cancer recurrence
AstraZeneca’s Trixeo approved in EU for asthma in patients aged 12 and over
Acumetis CEO Herspiegel steps down as Burden assumes role
Sobi’s olezarsen recommended for EU approval in severe hypertriglyceridaemia